LogoBiotechNW
The life science and biotech PR distribution service

Peptide Synthesis Webinar Series Introduces Second Installment: Synthesis of Difficult Peptide Sequences

biotage_logo

Uppsala, Sweden, October 25, 2010 / b3c newswire / – Biotage (STO: BIOT), a leading supplier of tools and technology for medicinal and analytical chemistry, announced the second installment in its series of webinars focusing on peptide synthesis. The free events are in part a result of the research collaboration with Professor Knud J. Jensen at the Faculty of Life Sciences, University of Copenhagen, in developing new applications on the Biotage Syro Wave™ Parallel Peptide Synthesizer in the field of synthetic peptide and protein chemistry. The collaboration builds on Professor Jensen’s previous research in developing novel chemistries for applications of solid-phase peptide synthesis.

 

There is no charge for the webinar series which is available for viewing at www.biotage.com/peptides

 

Introduced today is the second installment in the webinar series: Robotic Peptide Synthesizer with Microwave Heating, Synthesis of Difficult Peptide Sequences. Presented at the 31st European Peptide Symposium, Copenhagen, Denmark 2010, by A. Pernille Tofteng, Faculty of Life Sciences, University of Copenhagen.

 

The popular first webinar in the series: Microwave & Parallel Peptide Synthesizer: The Best of Both Worlds was also presented at the 31st European Peptide Symposium in Copenhagen, by Amit Mehrotra - Product Manager, Synthesis and Marketing Manager, Peptide Chemistry.

“We are very excited with the positive response we’ve received from professionals around the world regarding this webinar series.” says Amit Mehrotra “These free webinars are available at www.biotage.com/peptides, our dedicated resource for professionals. Coupled with our ongoing introduction of new products, our efforts illustrate that Biotage is dedicated to peptide professionals and are without question a leader in this important area.”

 

The webinar series was announced following the recent introduction of Biotage Resolux™ HPLC columns for peptide purification. Resolux premiered at the ACS Fall 2010 National Meeting & Exposition in Boston, Massachusetts USA and at the 31st European Peptide Symposium in Copenhagen, Denmark.

 

For more information regarding Biotage, please email This email address is being protected from spambots. You need JavaScript enabled to view it. or visit www.biotage.com/peptides.

 

 

About Biotage - www.biotage.com 
Biotage offers solutions, knowledge and experience in the areas of analytical and organic chemistry. The customers include the world’s top pharma and biotech companies, as well as leading academic institutes. The company is headquartered in Uppsala, Sweden, and has offices in the United States, United Kingdom and Japan. Biotage has 245 employees and had sales of SEK 394,1m in 2009. Biotage is listed on the NASDAQ OMX Nordic Stock Exchange. 

 

For further press information at Biotage please contact:
Rob Thompson
Director of Marketing Communications
10430 Harris Oaks Blvd. Suite C
Charlotte, North Carolina

USA
Tel: +1 704 654 4847
Fax: +1 704 654 4917
e-mail:This email address is being protected from spambots. You need JavaScript enabled to view it.

Cookies make it easier for us to provide you with our services. With the usage of our services you permit us to use cookies.
Ok